Monthly Archives: September 2026

Neurent Medical Secures €25 Million Growth Debt Facility from Claret Capital Partners to Accelerate Commercial Expansion

GALWAY, Ireland and BRAINTREE, Mass., Sept. 9, 2026 — Neurent Medical, the pioneer behind the NEUROMARK® System for the treatment of chronic rhinitis, today announced that it has secured a €25 million growth debt financing facility from Claret Capital Partners.

The financing will support the continued commercial expansion of NEUROMARK®, accelerate investment in sales and marketing initiatives, strengthen the company’s balance sheet, and provide additional capital to support future growth opportunities.

The financing follows Neurent Medical’s successful €62.5 million Series C financing completed earlier this year, further reinforcing the company’s position as a leader in minimally invasive treatments for chronic inflammatory sinonasal diseases.

Brian Shields, CEO of Neurent Medical said:

“This financing represents another important milestone for Neurent Medical as we continue to scale our commercial operations and expand patient access to NEUROMARK. We are delighted to deepen our relationship with Claret Capital Partners, whose continued support reflects confidence in our technology, clinical evidence, commercial progress and long-term vision. The facility provides significant financial flexibility while allowing us to continue executing our growth strategy with minimal dilution to shareholders.”

Daniel Mallon, Principal at Claret Capital Partners comments: 

“Neurent Medical has demonstrated exceptional progress in establishing NEUROMARK as a leading treatment option for chronic rhinitis. We are pleased to further support the company as it continues its commercial expansion and works to improve outcomes for millions of patients suffering from chronic rhinitis.”

About Neurent Medical

Neurent Medical is dedicated to transforming the treatment landscape for chronic inflammatory sinonasal diseases. Its flagship NEUROMARK® System utilizes proprietary impedance-controlled radiofrequency technology to target hyperactive posterior nasal nerves, offering durable relief from chronic rhinitis symptoms. The company is headquartered in Galway, Ireland, with U.S. operations in Braintree, Massachusetts.

For more information visit www.neurentmedical.com. 

About Claret Capital Partners

Claret Capital Partners is Europe’s largest independent growth debt fund manager. Since 2013, the firm has invested over €1.5bn through its funds, supporting more than 210 companies across the technology, life sciences and impact sectors. Its team has been active in investing into European companies for over 25 years, providing innovative debt solutions that help entrepreneurs and their investors grow their companies while minimising dilution.

For more information visit www.claret-capital.com 

Claret Capital Partners Limited (company registered number 12516001) is authorised and regulated by the Financial Conduct Authority (FRN 993228).

SOURCE Neurent Medical

Wint Raises $36 Million in Series D Funding to Scale AI-Powered Water Intelligence Globally

LIP Ventures and Inven Capital lead round as enterprise demand for water risk management accelerates

NEW YORK, Sept. 9, 2026 — Wint, the leading provider of water management solutions for the built environment, today announced it has raised $36 million in Series D funding co-led by LIP Ventures and Inven Capital. With this investment, Wint will accelerate product development and deepen the company’s market reach.

“Wint has established itself as the trusted platform for enterprise water intelligence, with a customer base and a track record that speaks for itself,” said Alan Weisleder, Partner at LIP Ventures. “This investment is an opportunity to help a proven team scale a proven solution to a much larger share of the global market, and we’re proud to be part of that journey.”

“Water risk is one of the most underestimated threats to the built environment. Wint exists to change that, and this funding gives us the resources to bring proactive water intelligence to every building, everywhere,” said Alon Geva, CEO at Wint. “Buildings that run on Wint leak less, waste less, and perform better, and this investment lets us scale to a much larger share of the world’s built environment.”

“We are excited to continue backing Wint as the leading water intelligence platform and key infrastructure layer for how buildings monitor, manage, and mitigate water-related risks,” said Michal Mravec, Investment Director at Inven Capital “The company’s growing traction with leading insurers, real estate owners, facility managers, and installation partners validates both the scale of the opportunity and Wint’s ability to create value across the entire water management ecosystem.”

Wint’s platform uses AI algorithms to analyze water data in commercial and industrial buildings in real time, giving facilities and risk teams precise visibility into where water is being used, wasted, or lost before damage occurs. The company serves global enterprises, commercial and residential facilities, general contractors, and mission-critical facilities seeking to halt water waste, prevent damage, lower operational costs, and strengthen their ESG impact.

This funding marks the latest milestone for Wint, which announced in December 2025 that it had secured a strategic investment from Grosvenor, one of the world’s most respected property owners and developers, who will expand Wint’s solutions across its global real estate portfolio. Heading into 2026, Wint reported saving 1.15 billion gallons of water, preventing an estimated $100 million in water damage across more than 1,300 incidents, and avoiding over 39,000 metric tons of carbon emissions in 2025 alone. The company also launched AI-based Water Insights and AI-driven water temperature and boiler health analysis, deepening the platform’s ability to surface actionable intelligence across every building system.

For more information about Wint, visit https://wint.ai.

About Wint

Wint is the leading provider of water management solutions for the built environment, protecting properties, ensuring business continuity, and driving sustainability at scale. As the only AI-powered, enterprise- and insurance-grade platform, Wint proactively prevents leaks, eliminates waste, and provides usage insights across every system and every stage of a building’s lifecycle. Backed by the industry’s only global insurer warranty and trusted by leaders like HP, Suffolk Construction, and the Empire State Building, Wint makes buildings smarter, safer, and more sustainable. Learn more wint.ai.

About LIP Ventures

LIP Ventures is a Latin America-based venture capital firm managing three funds with over US$220 million in AUM, deployed across a portfolio of 50+ early-growth and growth-stage technology companies. The firm connects international capital with technology talent across Israel, the United States, and Europe. Beyond funding, LIP Ventures supports its portfolio companies with market access, sales & marketing expertise, nearshoring capabilities, and professional services to drive revenue growth and long-term profitability.

Learn more at lip.lat.

About Inven Capital

Inven Capital is a EUR 500m European VC fund focused on later-stage climate tech investments in Europe & Israel, backed by CEZ Group and European Investment Bank (EIB). Inven Capital’s strategy is to invest in innovative fast growing climate tech startups, with a focus on decarbonization. It primarily focuses on later-stage growth investment opportunities with a sound business model proven by realized revenues and long-term growth potential. Since 2015, INVEN CAPITAL has selectively invested in over twenty companies including Sonnen, Sunfire, tado, Forto, Driivz, CyberX, Taranis, WINT, Ember, Andercore etc. For more information, visit www.invencapital.cz.

SOURCE Wint

System Raises $20M in Funding to Become the Trusted, Peptide-Native Platform for a New Era

System is positioned to become the go-to player in the $163B peptide market still searching for a leader as the FDA expands access to regulated compounds

SAN FRANCISCO, Sept. 9, 2026System, the vertically integrated peptide platform connecting patients with licensed U.S. clinicians and pharmacy-grade compound treatments, today announced $20M in new funding to accelerate its mission of becoming the definitive, trusted name in peptides. Funding comes from Patron Fund, Will Ventures, Vine, Courtside, Daybreak, SV Angel, and RiverPark Ventures. The fresh capital will give more people access to what has historically been reserved for a select group of patients.

Peptides have moved from niche biohacker interest to a mainstream wellness category, with the global peptide therapeutic market estimated at $140 billion in 2025 and projected to reach $163 billion in 2026. Despite a rising adoption of the longevity drugs known to support everything from anti-aging and skin rejuvenation to weight loss management, muscle growth, recovery, and energy enhancement, peptides have historically been costly, unregulated, and largely inaccessible. Now, on the heels of the FDA’s vote to add six reviewed peptides to the list of substances licensed compounding pharmacies can legally prepare, peptides are moving toward a more regulated, legitimate distribution model to serve the growing number of use cases.

System has been building the infrastructure to own the peptide supply chain as it enters a new era of regulation and access. The platform pairs patients with U.S.-licensed clinicians who evaluate individual health history and prescribe personalized peptide protocols, compounded by certified American pharmacies and shipped from lab to door. Differentiating itself from other suppliers and clinicians, System takes ownership by acquiring every link in the peptide supply chain, with a compounding pharmacy in its network and a raw-ingredient (API) manufacturer on its roadmap. Transparency is core to System’s operating model, with patients and regulators having visibility into what goes into every product and transaction: every product is third-party lab tested, clinicians are background-checked and NPDB-reviewed, and each treatment is sourced through FDA-registered U.S. compounding pharmacies.

“My vision was never to be another DTC telehealth brand, but to own more of the stack and build the foundation this category needs as it moves into the mainstream,” says Adam Steinle, Founder and CEO of System. “We want to be category definers and the solution Americans use and trust for their long-term health. This funding signals that we’re building a company that is filling the gap between concierge clinics and research-grade access that no single platform currently owns.”

“Peptides are moving from the edges of wellness into mainstream consumer culture. As healthcare becomes more personal, and increasingly part of how people express their identity, the category-defining companies will be built by founders who understand that trust, quality and brand are inseparable. Adam understood this consumer shift better than anyone. System is building the trusted consumer company that can define this category,” says Amber Atherton, Partner at Patron.

About System

System is a vertically integrated peptide platform delivering science-backed, physician-guided treatments through licensed U.S. clinicians and certified American compounding pharmacies. System’s peptide offerings include Glutathione, MIC+B12, NAD+, and Sermorelin to support energy, recovery, metabolism, muscle, skin, and healthy aging. Every medication is third-party lab-tested and shipped free within two days. Available in all 50 U.S. states, subject to state telehealth regulations. Learn more at systemlabs.com.

SOURCE System

Euno Raises $23 Million Series A to Build the AI Context Brain for the Enterprise

Euno’s AI context platform continuously learns how organizations build, use, and govern their data, giving AI agents the organizational intelligence they need to navigate enterprise data and act reliably. Acting as the AI brain behind enterprise data, Euno enables customers to move a wide range of AI initiatives from pilot to production in weeks.

Enterprise AI systems depend on trusted data to make decisions and take action. But agents need to understand what that data means, what to trust, how the business uses it, how they should use it, and how it connects across the organization. As enterprises move toward autonomous, cross-domain agentic workflows, they need a new foundation: context that learns with the organization, sustains trust as knowledge evolves, and gives every agent the organizational intelligence it needs to act reliably, while generating its own context feedback loops.

Euno replaces human-maintained context with a live, AI-native brain that understands how data flows, what it means, and how it is used across the organization, then learns how agents interact with that context as they reason and act across complex, multi-domain workflows. Euno gives each agent exactly the slice of context its task and decision require, while continuously encoding what it learns back into the organization’s context platform, building the foundation for a sustainable, compounding AI advantage.

“Models keep getting better and cheaper, but the long-term AI moat for enterprises will increasingly come from the accumulated record of how work gets done,” said Sarah Levy, co-founder and CEO of Euno. “Competitors may have access to the same frontier models, but they cannot easily replicate the proprietary context and experience an enterprise has accumulated through its own operations.”

At the core of Euno’s research is how to best capture institutional knowledge, including whether it can be inferred from operational signals rather than manually curated and maintained. Through its studies, Euno has found that much of what determines the data to use and trust, and how to use it, is encoded in patterns across continuously evolving metadata graphs. By analyzing these patterns, Euno can infer that knowledge, then continuously refine it through agent feedback as the organizational context evolves. These findings shaped Euno’s architecture, enabling its customers to put AI to work with their data in weeks, rather than spend a year getting AI-ready.

Building the context brain that allows agents to move into production requires more than giving them the right context. Enterprises also need to govern what context each agent is allowed to access and under what rules. Euno builds governance directly into its context infrastructure, delivering only the context each agent’s task and role require while enforcing organizational boundaries in real time.

“The teams that own enterprise data have been the ones slowing AI down, and they were right to do so because nobody could tell them what an agent would be able to reach once it was connected,” Levy said. “Security vendors sell them the fear. We hand them the ability to actually deploy and build the organizations of the future.”

“Enterprises are thirsty for impact-making AI agents. For an AI agent to move the needle, it must act on current and trusted business data – and that demands precise, scalable contextual infrastructure,” said Moshe Zilberstein, General Partner at N47. “Demand for this AI infrastructure is accelerating fast, and Euno is the only company building it AI-native instead of retrofitting a solution meant for people. Sarah and Eyal are data experts and have world-class engineering depth, which is exactly what this kind of problem demands.”

Euno was named to Gartner’s Coolest Vendor Innovations in Data Management report, which credits the company’s continuously updated enterprise context graph with giving AI systems semantic understanding of data assets. Euno works with Fortune 500 organizations and enterprises across all verticals, including the market intelligence platform AlphaSense and the global telecommunications company Zayo Group.

“After years of implementing data governance solutions at the top two telecom providers in the United States, encountering Euno was a turning point. With it, I realized we no longer needed to follow the traditional playbook and build a data catalog, but could leap ahead with an AI-driven approach,” said Will Mitchell, director of data and AI governance at Zayo. “This shift saved significant time, without needing to build complex models or manually create canonical models”

Euno was founded in 2023 by Sarah Levy and Eyal Firstenberg, both graduates of Talpiot, the Israeli military’s elite technology program. Both have deep research and science backgrounds, Levy was previously CTO at Sight Diagnostics and head of a top IDF cybersecurity department. Firstenberg, who leads the company’s San Francisco office, was a section head in Unit 8200 and then served as VP of R&D at LightCyber, which was acquired by Palo Alto Networks. The company employs nearly 30 people across the US and Israel, including a context-focused research group, and expects to double by year-end, with the funding secured in this round going primarily to sales, marketing, and AI research.

About Euno
Euno is the enterprise AI-native context platform, built for how AI agents work. Euno’s context brain continuously researches, reconstructs and defines lineage, meaning, ownership, and governance rules across the entire data and AI stack, enabling accurate and resilient results and the deployment of autonomous AI agents across the organization. By ensuring every agent receives precisely the context it needs, and nothing more, Euno enables enterprises to confidently run autonomous agents in production, while maintaining full control of trust, governance and economics. Founded in 2023, Euno is based in San Francisco and Tel Aviv and backed by N47, 10D, and leading data and security founders, and was named to Gartner’s Coolest Vendor Innovations in Data Management report in 2026. Learn more at euno.ai.

[email protected]

SOURCE Euno

MCatalysis Closes $5M Seed Round to Produce Low-Carbon Fuel below Commodity Cost

LONDON and DALLAS, Sept. 9, 2026 — MCatalysis, Inc. announces today the closing of its $5 million Seed funding round to commercialize its next-generation chemical process to convert domestic offgas, plastics, and biomass resources into energy-secure, drop-in fuels below commodity cost. The round was led by HL Energy Ventures (HLEV) and Oxford Science Enterprises (OSE), and is further supported by a recent $2.25 million award from UK Research and Innovation.

Conventional fuel refining and early synthetic alternatives require massive energy inputs, extreme temperatures, and complex, multi-stage facilities that elevate expenses. MCatalysis takes an entirely different path. Rather than relying on brute furnace heat, the company invented a unique suite of proprietary microwave-driven catalysts, smart materials that act like molecular scissors and glue, to produce high-quality, ready-to-use fuels compatible with existing infrastructure. 

MCatalysis will use the proceeds to construct an industrial pilot facility at the Axel’One platform in Lyon, France, situated in Europe’s premier chemical manufacturing hub, the Vallée de la Chimie. Locating in this industrial corridor enables the company to leverage established infrastructure and chemical engineering talent. R&D efforts will continue to be centered in London.

“Cost is everything; businesses cannot switch energy sources if alternatives carry a premium,” said Michael D. Irwin, CEO of MCatalysis. “Our platform is engineered to make commercial fuel at costs required by today’s market. By winning on economics first, clean adoption becomes an automatic decision.”

“MCatalysis innovatively provides its initial solution at the core of already existing fuels infrastructure, allowing it to provide low carbon fuels at low cost and without requiring government subsidies,” stated Victor Liu, of HL Energy Ventures. “We have been supporting MCatalysis since its very beginning, and will continue to support Michael and the MCatalysis team as they scale operations.”

“Scalable transitions require superior unit economics,” added George Todd, of OSE. “MCatalysis slashes fuel manufacturing costs, creating a compelling commercial model that delivers environmental sustainability as a natural result. We are delighted to support this breakthrough Oxford University research into global deployment.”

About MCatalysis, Inc.

MCatalysis is a technology company that produces high-quality, drop-in fuels without petroleum extraction from unmonetized hydrocarbon feedstocks. Learn more at www.mcatalysis.com.

About HL Energy Ventures

HL Energy Ventures is a venture capital firm that invests in early-stage startups addressing energy security, energy AI, and the energy transition. Learn more at www.hlenergyventures.com.

About Oxford Science Enterprises

Oxford Science Enterprises (OSE) is an independent, billion-pound investment company and venture builder that finds, funds, and builds transformational science and technology companies emerging from Oxford’s world-leading research.  Learn more at www.oxfordscienceenterprises.com.

Media & Investor Contact

SOURCE MCatalysis, Inc.

TCS Blockchain Now Truckin’ on Kraken; $TCS Token Lists for Trading

Digital asset freight settlement at Kraken, via token listing, delivers savings and opportunity

CASPER, Wyo., Sept. 9, 2026TCS Blockchain, a Wyoming trade finance provider serving the transportation industry, today announced its digital asset, TCS Token ($TCS), is listed on Kraken with a USD spot trading pair. The listing provides $TCS liquidity on Kraken to support freight invoice settlement, and eligible Kraken clients can trade and engage $TCS.

Transportation Industry experts place annual freight spend volume at $2.58 trillion, 9% of total US GDP. The American Trucking Association reports 72% of freight moves by truck, and 91% of carriers operate 1-10 trucks. Carriers wait 30-180 days to get paid, forcing most to sell invoices to financial intermediaries at substantial capital costs.

TCS and Kraken Drive Value

TCS converged supply chains with blockchains to solve the problem. Transportation companies now exchange freight invoice collection rights for $TCS, which can then be sold for USD at Kraken. According to TCS, Users are funded same-day or next business day, and most save 50-90% on costs. TCS Users move seamlessly from $TCS to USD in a single market, rather than navigating layers of intermediaries and third-party digital assets. The model reduces costs, operational complexity and counterparty risk.

Kraken’s listing of $TCS provides transportation companies with cheaper and faster settlement, and opportunity for Kraken clients to engage with the digital asset driving value and facilitating commercial paper transactions in a legacy industry.

About the $TCS Asset

$TCS is an ERC-20 asset deployed on the Polygon network, with supply capped at fifty-billion. TCS reports nearly all supply has been held in treasury since 2022. After TCS settles with transportation Users, new $TCS supply is released when Users sell on Kraken for USD – similar to how the efforts of miners bring new Bitcoin supply to market.

“TCS saves trucking and transportation companies time and money. And eliminating financial waste in supply chains helps everyone,” advised Todd Ziegler, TCS Blockchain CEO. “TCS is a Main Street digital asset solution, that’s solved the largest B2B payments problem in America. Kraken clients can now be part of this innovation, and engage with the companies that get their goods to grocery and retail store shelves every day.”

About Kraken

Founded as a secure global crypto exchange in 2011, Kraken has evolved into a multi-asset trading platform. From one account, customers trade more than 600 digital assets, thousands of U.S.-listed stocks and ETFs, hundreds of tokenized equities, derivatives, including perpetuals, and national currencies. Millions of consumers, professional traders, and institutions rely on Kraken as one of the fastest and most liquid trading platforms.

About TCS Blockchain

TCS Blockchain settled the World’s first freight invoice onchain in 2022, and now offers the cheapest, fastest and best settlement experience in the American transportation Industry. TCS supports truckers, brokers, and at-scale carriers – and benefits consumers and households – by displacing invoice factoring, and mitigating financial waste in supply chains.

Media Contacts

TCS Blockchain, 307-554-1090, [email protected], Kraken, [email protected]

SOURCE TCS Blockchain & Kraken

BEEP CLOSES SERIES B TO ACCELERATE COMMERCIAL DEPLOYMENT OF AUTONOMOUS MOBILITY NETWORKS

ROUND LED BY AUTONOMOUS VEHICLE TECHNOLOGY LEADER MOBILEYE

LAKE NONA, Fla., Sept. 9, 2026 — Beep, Inc., a leading U.S. provider of autonomous mobility solutions, today announced the close of a Series B funding round, bringing its total capital raised to approximately $130 million. The round was led by Mobileye, a global leader in autonomous vehicle technology and advanced driver-assistance systems, with participation from existing investors.

The new capital will help Beep scale and expand its mobility-as-a-service offerings, deepen its work with technology and public-sector partners, and continue deployment of its AI-driven AutonomOS platform, which builds upon Beep’s years of expertise as an AV operator to reduce the complexity required for the management and orchestration of Physical AI networks in transportation.

“Mobileye and Beep have been working closely on AV deployment projects, and our excitement for the future of improving transportation through applied physical AI on the road has never been greater,” said Kobi Ohayon, Chief Operations Officer at Mobileye. “Beep plays an essential role in the emerging AV ecosystem across the United States, and its deployment platform will become increasingly important as more AV services come to market across vehicle types and business models.”

Mobileye’s investment reflects a shared strategic vision for bringing a range of autonomous mobility models, from fixed-route services to on-demand microtransit, to commercial scale in the United States in response to clear customer demand.

“This strategic investment round, led by Mobileye and supported by our longstanding investor partners, positions Beep to deliver fully on its vision,” said Kevin Reid, CEO and Chairman of Beep. “The investment enables us to strengthen and expand our shared autonomous mobility solutions, helping communities move people in ways that are safer, smarter, and more connected.”

For Beep, the round marks both a financial milestone and a validation of the company’s position as the essential transit partner for modern mobility, delivering real-world autonomous service operations enabled by leading-edge technology.

About Beep, Inc.
Beep, Inc. delivers the next generation of autonomous mobility networks through its mobility-as-a-service offerings and AutonomOS mobility operating system. Specializing in planning, deploying, and managing autonomous transportation networks, Beep connects people, places, goods, and services with solutions designed to improve safety, reduce congestion, and expand access to mobility. Leveraging artificial intelligence and real-world operational experience, Beep’s U.S.-domiciled, human-in-the-loop platform enables scalable and reliable autonomous transit deployments across public and private communities.

Media Contact: Alex Poirot, [email protected]

About Mobileye
Mobileye (Nasdaq: MBLY) leads the mobility revolution with autonomous driving and driver-assistance technologies, harnessing world-renowned expertise in artificial intelligence, computer vision and integrated software and hardware. Since its founding in 1999, Mobileye has enabled the global adoption of advanced driver-assistance systems that save countless lives and reduce crashes, while pioneering technologies such as REM™ crowdsourced road intelligence, Imaging Radar and Compound AI. In 2026, Mobileye acquired Mentee Robotics to pursue the future of physical AI and humanoid robots. More than 250 million vehicles worldwide have been built with Mobileye’s EyeQ technology inside. Since 2022, Mobileye has been listed independently from Intel (Nasdaq: INTC), which retains majority ownership. For more information, visit www.mobileye.com.

Media Contact: Alexis Blais, [email protected]

SOURCE Beep, Inc.

Adani Airports will rund 1 Milliarde US-Dollar an Erstkapital von namhaften internationalen Investoren einwerben

Investition von Alpha Wave Global, Premji Invest, Temasek und BlackRock  Die von diesen Unternehmen verwalteten Fonds bewerten AAHL mit einer Eigenkapitalbewertung vor der Finanzierungsrunde von rund 18 Milliarden US-Dollar.

Zusammenfassung der Redaktion

  • Adani Airport Holdings Limited (AAHL) hat verbindliche Vereinbarungen geschlossen, um 9.825 Crores (~1 Mrd. USD) an Primärkapital von einem Konsortium führender inländischer und globaler Investoren zu beschaffen.
  • Die Transaktion bewertet AAHL mit einer Pre-Money-Bewertung von ca.18 Milliarden US-Dollar, und setzt damit einen bedeutenden externen institutionellen Bewertungsmaßstab für die Flughafenplattform.
  • Das Investorenkonsortium setzt sich zusammen aus , Alpha Wave Global, , Premji Invest, Temasek und BlackRock sowie den verwalteten Fonds. Nach Abschluss aller drei Tranchen werden die Investoren insgesamt rund 5,54 % an AAHL halten.
  • Die Erlöse werden zur Modernisierung des Flughafens und zum Ausbau der Kapazitäten verwendet, um jährlich rund 200 Millionen Passagiere abzufertigen, sowie zur integrierten Entwicklung der Adani Airport City mit einer Fläche von rund 22 Millionen Quadratfuß für eine gemischt genutzte Bebauung in der ersten Phase und zum weiteren Ausbau der Bodenabfertigungs- und nicht-luftfahrtbezogenen Geschäftsbereiche von AAHL.

AHMEDABAD, Indien, 9. September 2026 — Adani Airport Holdings Limited (AAHL), eine Tochtergesellschaft von Adani Enterprises Limited (AEL) und einer der größten privaten Flughafenbetreiber Indiens, hat verbindliche Vereinbarungen getroffen, um 982,5 Crore Rupien (~1 Milliarde US-Dollar) an Primärkapital von einem Investorenkonsortium zu beschaffen, das sich aus Alpha Wave Global, Premji Invest, Temasek sowie von BlackRock verwalteten Fonds. Die Transaktion bewertet AAHL mit einer Eigenkapitalbewertung vor der Finanzierungsrunde von rund 18 Milliarden US-Dollar und stellt eine der größten Primärkapitalbeteiligungen von Finanzinstituten im indischen Flughafeninfrastruktursektor dar.

Die Beteiligung eines Konsortiums aus langjährigen inländischen und internationalen Investoren ist ein deutliches Zeichen des Vertrauens der institutionellen Anleger in die Größe, die operative Leistungsfähigkeit und das langfristige Wachstumspotenzial von AAHL. Die Investition bringt institutionelles Kapital mit langer Laufzeit in das Unternehmen, und zwar zu einem Zeitpunkt, an dem der indische Luftverkehrssektor in eine Phase anhaltenden Passagierwachstums, Kapazitätsausbaus und Infrastrukturinvestitionen eintritt.

AAHL und die Investoren haben einen Aktienzeichnungsvertrag sowie eine Aktionärsvereinbarung geschlossen, wonach die Investoren in drei Tranchen neue Stammaktien von AAHL zeichnen werden, wobei die letzte Tranche voraussichtlich bis Juli 2027 abgeschlossen sein wird. Nach Abschluss aller drei Tranchen werden die Investoren insgesamt rund 5,54 % an AAHL halten.

Die Einnahmen werden drei strategische Schwerpunkte unterstützen: Ausbau und Modernisierung der Flughafeninfrastruktur im gesamten Portfolio von AAHL; Beschleunigung der Entwicklung integrierter „Adani Airport City”-Ökosysteme rund um die Flughäfen mit der Errichtung von rund 22 Millionen Quadratfuß gemischt genutzter Flächen, die in der ersten Phase geplant sind; sowie Ausbau der passagierorientierten und anderer nicht-luftfahrtbezogener Geschäftsbereiche, einschließlich unseres Bodenabfertigungsgeschäfts. Diese Investitionen sollen die Kapazität auf jährlich rund 200 Millionen Passagiere erhöhen, die kommerzielle Ertragssteigerung vorantreiben, das Passagiererlebnis verbessern und das integrierte Flughafen-Ökosystem von AAHL weiter stärken.

Die Transaktion folgt auf die erfolgreiche qualifizierte institutionelle Platzierung (QIP) von AEL im Umfang von 15.000 Crore Rupien im Juli 2026, Indiens größte QIP durch ein Nicht-Finanzunternehmen. Insgesamt spiegeln diese Transaktionen wider, dass das Adani-Portfolio weiterhin Zugang zu erheblichen Mengen an langfristigem inländischem und globalem institutionellem Kapital hat.

„Diese Partnerschaft ist ein wichtiger Meilenstein beim Ausbau der Adani Airports-Plattform, und wir fühlen uns geehrt, auf diesem Weg so namhafte, langfristige Investoren an unserer Seite zu haben”, sagte Herr Jeet Adani, nicht geschäftsführender Direktor der Adani Airport Holdings Limited. „Indiens Luftfahrtsektor ist einer der stärksten Multiplikatoren für das BIP-Wachstum des Landes. Jeder Ausbau des Flugverkehrs wirkt sich positiv auf Handel, Tourismus, Beschäftigung und regionale Entwicklung aus – und zwar weit über das Flughafengelände hinaus. Mit der Unterstützung dieser Partner werden wir weiterhin im Vorgriff auf dieses Wachstum investieren und unsere Infrastruktur, unsere städtebaulichen Projekte sowie unsere nicht-luftfahrtbezogenen Geschäftsbereiche ausbauen, um eine der weltweit führenden integrierten Flughafenplattformen zu schaffen.”

„Wir werden die Kapazitäten von AAHL weiter ausbauen, um das Unternehmen zur weltweit größten Flughafenplattform zu machen”, sagte Arun Bansal, CEO der Adani Airport Holdings Limited. „Dieses Ziel wird durch die exponentiellen Wachstumschancen in ganz Indien, die steigende Kaufkraft der indischen Verbraucher und die Dynamik unserer Stadtentwicklungsprojekte als starke wirtschaftliche Impulsgeber in den großen Ballungszentren des Landes gestützt. Wir sind unseren Partnern für ihr Vertrauen zutiefst dankbar und freuen uns darauf, diesen Weg gemeinsam weiterzugehen, während wir eine Flughafenplattform von wahrhaft weltklasse für Indien aufbauen.”

Die wichtigsten Berater bei dieser Transaktion waren Cyril Amarchand Mangaldas, AZB & Partners, JSA Advocates and Solicitors, TT&A Advocates and Solicitors, Jefferies India Private Limited, SBI Capital Markets Limited und Ernst & Young LLP.

Die Transaktion unterliegt den üblichen aufschiebenden Bedingungen, einschließlich des Erhalts der erforderlichen Genehmigungen.

Luma Group Successfully Closes LumaBio Fund I at $410 Million

NEW YORK, Sept. 9, 2026 — Luma Group (“the Firm”), a New York-based investment firm focused on life sciences, today announced the successful final close of LumaBio I LP (“LumaBio Fund I” or “the Fund”), its inaugural life sciences venture capital fund, with $410 million in committed capital. LumaBio Fund I is backed by a global investor base, including leading financial institutions, sovereign wealth funds, insurance companies, family offices and ultra-high-net-worth individuals.

Luma Group was founded on the simple conviction that the convergence of biology, chemistry, physics and artificial intelligence will fundamentally reshape medicine. As scientific understanding deepens and computational capabilities continue to accelerate discovery and development, the Firm believes that the next generation of life sciences companies will emerge with the potential to transform patient care and improve human health.

Structured as a 15-year investment vehicle, the Fund plans to invest early alongside exceptional entrepreneurs and groundbreaking science, with the flexibility to support its highest-conviction companies through key milestones from discovery to commercialization.

“We founded Luma Group on the belief that extraordinary science, supported by patient, long-term capital, has the power to improve millions of lives,” said Joshua Fink, Founder and Managing Member of Luma Group. “This Fund represents more than capital – it is a commitment to partnering with extraordinary innovators as they translate visionary science into life-changing medicines. That commitment is made possible by the trust and confidence of our investors.”

“The coming decade will fundamentally reshape medicine as once-distinct scientific disciplines converge and the pace of discovery and translation accelerates,” added Themasap Khan, PhD, Co-Founder and Partner of Luma Group. 

Since its inception in 2023, LumaBio Fund I has invested in companies with the potential to transform medicine, including Aeovian Pharmaceuticals, Altos Labs, Arsenal Biosciences, Character Biosciences, Coultreon Biopharma, Curve Biosciences, Integrated Biosciences, SciThera, Vaccine Company and several others in stealth.

Earlier this year, LumaBio Fund I announced its first exit with the acquisition of Vaccine Company by Eli Lilly and Company in a transaction valued at up to $1.55 billion. This transaction reflects the Firm’s strategy of identifying differentiated scientific platforms early and partnering closely with management teams through key value-creation milestones.

About Luma Group

Luma Group is a New York–based investment firm focused on the life sciences. The Firm combines scientific expertise, computational insight and a proprietary artificial intelligence platform to inform its investment strategy and support the companies that the Firm identifies, builds and backs. Luma Group partners with founders advancing transformative scientific and clinical innovation across the global life science ecosystem.

Media Contacts
Bill Ryan
Chief Financial Officer, Luma Group
[email protected]

Richie Santry
Chief of Staff, Luma Group
[email protected] 

SOURCE Luma Group